Related Experiment Video
Updated: Jan 29, 2026
05:26
Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
Published on: March 1, 2024
1.9K
Emphysematous Gastritis in a Patient with Untreated Cyclic Vomiting Syndrome
Sara L Robinson1, Brett W Sadowski2, Christa Eickhoff3
1Department of Medicine, Division of General Internal Medicine, Walter Reed National Military Medical Center, Bethesda, MD.
ACG Case Reports Journal
|February 19, 2019
Summary
Emphysematous gastritis (EG), a rare infection causing gastric air, is a newly identified complication of cyclic vomiting syndrome. This case highlights how untreated functional bowel disorders can lead to severe, life-threatening conditions.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Internal Medicine
Background:
- Emphysematous gastritis (EG) is a rare, severe condition characterized by gastric pneumatosis due to infection.
- Cyclic vomiting syndrome (CVS) is a functional gastrointestinal disorder with recurrent episodes of nausea and vomiting.
Observation:
- A patient with a history of cyclic vomiting syndrome presented with acute illness.
- Radiographic, endoscopic, and histologic findings confirmed the presence of emphysematous gastritis.
Findings:
- This case is the first to report emphysematous gastritis as a complication of cyclic vomiting syndrome.
- The findings suggest a link between untreated functional bowel disorders and severe infectious complications.
Implications:
- This case underscores the potential for severe, life-threatening complications arising from untreated functional gastrointestinal disorders like CVS.
- Recognizing EG as a potential complication of CVS is crucial for timely diagnosis and management.
- Further research is warranted to explore the pathophysiology and management strategies for EG in the context of CVS.
Related Concept Videos
01:17Gastritis-II: Pathophysiology
1.2K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K
01:22Pathophysiology of Vomiting
3.0K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.0K
01:27Gastritis-I: Introduction and Types
2.3K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
2.3K
01:23Gastritis III: Clinical Manifestations and Management
1.2K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.2K
02:33Stereoisomerism of Cyclic Compounds
11.1K
In this lesson, we delve into the role of ring conformation and its stability, which determines the spatial arrangement and, consequently, the molecular symmetry and stereoisomerism of cyclic compounds. 1,2-Dimethylcyclohexane is used as a case study to evaluate the possible number of stereoisomers. Here, given the multiple (n = 2) chiral centers, there are 2n = 4 possible configurations that lack a plane of symmetry, as the ring skeleton exists in a non-planar chair conformation. In addition,...
11.1K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
779
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
779